101 related articles for article (PubMed ID: 1982269)
1. Anticonvulsant action of SCH 23390 in the striatum of the rat.
al-Tajir G; Starr MS
Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
[TBL] [Abstract][Full Text] [Related]
2. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
3. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
Alam AM; Starr MS
Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
[TBL] [Abstract][Full Text] [Related]
5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
al-Tajir G; Chandler CJ; Starr BS; Starr MS
Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
[TBL] [Abstract][Full Text] [Related]
7. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra.
al-Tajir G; Starr MS
Pharmacol Biochem Behav; 1991 May; 39(1):109-13. PubMed ID: 1924492
[TBL] [Abstract][Full Text] [Related]
8. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat.
Damsma G; Tham CS; Robertson GS; Fibiger HC
Eur J Pharmacol; 1990 Sep; 186(2-3):335-8. PubMed ID: 1981190
[TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat.
Alam AM; Starr MS
Neuroscience; 1994 Jun; 60(4):1039-47. PubMed ID: 7936204
[TBL] [Abstract][Full Text] [Related]
11. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
Levin ED; Ellison GD; See RE; South D; Young E
Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
Wahnschaffe U; Löscher W
Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum.
Teicher MH; Gallitano AL; Gelbard HA; Evans HK; Marsh ER; Booth RG; Baldessarini RJ
Brain Res Dev Brain Res; 1991 Nov; 63(1-2):229-35. PubMed ID: 1686425
[TBL] [Abstract][Full Text] [Related]
15. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
Merchant KM; Gibb JW; Hanson GR
Eur J Pharmacol; 1989 Feb; 160(3):409-12. PubMed ID: 2565819
[TBL] [Abstract][Full Text] [Related]
16. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
Yoshikawa T; Fukamauchi F; Shibuya H; Takahashi R
Neuropeptides; 1989; 13(2):103-5. PubMed ID: 2567971
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
18. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
[TBL] [Abstract][Full Text] [Related]
19. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits?
al-Tajir G; Starr MS
Neuroscience; 1991; 43(1):51-7. PubMed ID: 1681459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
